FrancophonIA/ELRC3.0 huggingface dataset:
English: The contents of the Monovial are added to small volume infusion bags containing 0.9% Sodium Chloride Injection, or 5% Dextrose Injection, or another compatible fluid.
Slovenian: Vsebino monoviale je treba dodati v infuzijske vrečke majhne prostornine, ki vsebujejo 0,9 % raztopino natrijevega klorida za injiciranje, 5 % raztopino glukoze za injiciranje ali drugo kompatibilno tekočino.
English: For every 1 kg the baby or child weighs, they'll be given 30 to 100 mg of Zinacef per day divided in three or four doses.
Slovenian: Dojenček oziroma otrok bo dobil od 30 do 100 mg zdravila Zinacef na kilogram telesne mase na dan, razdeljeno na tri ali štiri odmerke.
English: How to store Zinacef
Slovenian: Kako uporabljati zdravilo Zinacef
English: 1 g powder for solution for injection 1 g intramuscular intravenous bolus
Slovenian: 1 g prašek za raztopino za injiciranje 1 g intramuskularno intravenski bolus
English: In patients with hepatic dysfunction this is not expected to effect the pharmacokinetics of cefuroxime.
Slovenian: Ni pričakovati, da bi moteno delovanje jeter vplivalo na farmakokinetiko cefuroksima.
English: Complicated urinary tract infections, including pyelonephritis
Slovenian: zapletene okužbe sečil, vključno s pielonefritisom
English: <{fax}> <{e-mail}>
Slovenian: {DD. mesec YYYY}
English: Cefuroxime is primarily excreted by the kidneys.
Slovenian: Cefuroksim se izloča predvsem skozi ledvice.
English: How to store Zinacef [To be completed nationally] Keep this medicine out of the sight and reach of children.
Slovenian: Shranjevanje zdravila Zinacef [izpolni država članica] Zdravilo shranjujte nedosegljivo otrokom!
English: Zinacef is also used:
Slovenian: Zdravilo Zinacef se uporablja tudi za:
English: Preparation of solution for intravenous infusion
Slovenian: Priprava raztopine za intravensko infundiranje
English: As a false negative result may occur in the ferricyanide test, it is recommended that either the glucose oxidase or hexokinase methods are used to determine blood/plasma glucose levels in patients receiving cefuroxime sodium.
Slovenian: Za določevanje glukoze v krvi/plazmi bolnikov, ki prejemajo natrijev cefuroksimat, je priporočljivo uporabljati glukoza oksidazno ali heksokinazno metodo.
English: Hepatobiliary disorders transient rise in liver enzymes transient rise in bilirubin
Slovenian: Bolezni jeter, žolčnika in žolčevodov prehodno povečane vrednosti jetrnih encimov prehodno povečane vrednosti bilirubina
English: Uncommon side effects that may show up in blood tests:
Slovenian: Občasni neželeni učinki, ki se lahko pokažejo pri preiskavah krvi:
English: As with all beta-lactam antibacterial agents, serious and occasionally fatal hypersensitivity reactions have been reported.
Slovenian: Opisane so bile resne in občasno smrtne preobčutljivostne reakcije, tako kot pri vseh betalaktamskih protibakterijskih zdravilih.
English: 1.5 g powder for solution for injection or infusion 1.5 g intramuscular intravenous bolus intravenous infusion
Slovenian: 1,5 g prašek za raztopino za injiciranje ali infundiranje 1,5 g intramuskularno intravenski bolus intravenska infuzija
English: 750 mg powder for solution for injection or infusion 750 mg intramuscular intravenous bolus intravenous infusion
Slovenian: 750 mg prašek za raztopino za injiciranje ali infundiranje 750 mg intramuskularno intravenski bolus intravenska infuzija
English: Gastrointestinal disorders gastrointestinal disturbance pseudomembranous colitis
Slovenian: Bolezni prebavil gastrointestinalne motnje psevdomembranozni kolitis
English: 500 mg powder for solution for injection 500 mg intramuscular
Slovenian: 500 mg prašek za raztopino za injiciranje 500 mg intramuskularno
English: 250 mg powder for solution for injection
Slovenian: 250 mg prašek za raztopino za injiciranje
English: • Complicated urinary tract infections, including pyelonephritis.
Slovenian: • zapletene okužb sečil, vključno s pielonefritisom;
English: Cefuroxime sodium (5 mg/ml) in 5% w/v or 10% w/v xylitol injection may be stored for up to 24 h at 25oC.
Slovenian: Natrijev cefuroksimat (5 mg/ml) lahko v 5 % m/V ali 10 % m/V raztopini ksilitola za injiciranje shranjujemo do 24 ur pri temperaturi 25oC.
English: You must look out for certain symptoms such as allergic reactions and gastrointestinal disorders such as diarrhoea while you are being given Zinacef.
Slovenian: Med prejemanjem zdravila Zinacef morate biti pozorni na določene simptome, npr. na alergijske reakcije in na prebavne motnje, kakršna je driska.
English: At least 6 mL At least 6 mL
Slovenian: 3 ml vsaj 6 ml vsaj 6 ml
English: Your doctor or nurse will dispose of any medicine that is no longer required.
Slovenian: O načinu odstranjevanja zdravila, ki ga ne uporabljate več, se posvetujte s farmacevtom.
English: General disorders and administration site conditions injection site reactions which may include pain and thrombophlebitis Description of selected adverse reactions Cephalosporins as a class tend to be absorbed onto the surface of red cell membranes and react with antibodies directed against the drug to produce a positive Coomb's test (which can interfere with cross matching of blood) and very rarely haemolytic anaemia.
Slovenian: Splošne težave in spremembe na mestu aplikacije reakcije na mestu injiciranja, ki lahko vključujejo bolečine in tromboflebitis Opis izbranih neželenih učinkov Antibiotiki iz skupine cefalosporinov imajo tendenco adsorpcije na membrane eritrocitov in reagiranja s protitelesi proti zdravilu.
English: PHARMACEUTICAL PARTICULARS 6.1 List of excipients [To be completed nationally] 6.2 Incompatibilities [To be completed nationally] 6.3 Shelf life
Slovenian: 6.2 Inkompatibilnosti [izpolni država članica] 6.3 Rok uporabnosti [izpolni država članica]
English: 750 mg powder for solution for injection or infusion Austria - Curocef
Slovenian: 750 mg prašek za raztopino za injiciranje ali infundiranje Avstrija - Curocef
English: Zinacef and associated names (see Annex I) 250 mg powder for solution for injection Zinacef and associated names (see Annex I) 750 mg powder for solution for injection Zinacef and associated names (see Annex I) 1.5 g powder for solution for injection Zinacef and associated names (see Annex I) 250 mg powder and solvent for solution for injection Zinacef and associated names (see Annex I) 500 mg powder and solvent for solution for injection Zinacef and associated names (see Annex I) 750 mg powder and solvent for solution for injection Zinacef and associated names (see Annex I) 1 g powder and solvent for solution for injection Zinacef and associated names (see Annex I) 750 mg powder for solution for infusion Zinacef and associated names (see Annex I) 1.5 g powder for solution for infusion Zinacef and associated names (see Annex I) 2 g powder for solution for infusion Zinacef and associated names (see Annex I) 250 mg powder for solution for injection or infusion Zinacef and associated names (see Annex I) 750 mg powder for solution for injection or infusion Zinacef and associated names (see Annex I) 1.5 g powder for solution for injection or infusion Zinacef and associated names (see Annex I) 750 mg powder for solution for infusion (Monovial presentation) Zinacef and associated names (see Annex I) 1.5 g powder for solution for infusion (Monovial presentation)
Slovenian: Zinacef in povezana imena (glejte Prilogo I) 250 mg prašek za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 750 mg prašek za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 1,5 g prašek za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 250 mg prašek in vehikel za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 500 mg prašek in vehikel za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 750 mg prašek in vehikel za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 1 g prašek in vehikel za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 750 mg prašek za raztopino za infundiranje Zinacef in povezana imena (glejte Prilogo I) 1,5 g prašek za raztopino za infundiranje Zinacef in povezana imena (glejte Prilogo I) 2 g prašek za raztopino za infundiranje Zinacef in povezana imena (glejte Prilogo I) 250 mg prašek za raztopino za injiciranje ali infundiranje Zinacef in povezana imena (glejte Prilogo I) 750 mg prašek za raztopino za injiciranje ali infundiranje Zinacef in povezana imena (glejte Prilogo I) 1,5 g prašek za raztopino za injiciranje ali infundiranje Zinacef in povezana imena (glejte Prilogo I) 750 mg prašek za raztopino za infundiranje (monoviala) Zinacef in povezana imena (glejte Prilogo I) 1,5 g prašek za raztopino za infundiranje (monoviala)
English: T1/2 (hrs)
Slovenian: Očistek kreatinina t1/2 (ure)
English: For every 1 kg the baby weighs, they'll be given 30 to 100 mg Zinacef per day divided in two or three doses.
Slovenian: Dojenček bo dobil od 30 do 100 mg zdravila Zinacef na kilogram telesne mase na dan, razdeljeno na dva ali tri odmerke.
English: Pain at the intramuscular injection site is more likely at higher doses.
Slovenian: Verjetneje je, da se bo bolečina na mestu intramuskularnega injiciranja pojavila pri višjih odmerkih, vendar pa je malo verjetno, da bo zaradi bolečine zdravljenje potrebno opustiti.
English: Amount of sodium per vial
Slovenian: Količina natrija na vialo
English: Zinacef and associated names (see Annex I) 750 mg powder for solution for injection Zinacef and associated names (see Annex I) 1.5 g powder for solution for injection Zinacef and associated names (see Annex I) 250 mg powder and solvent for solution for injection Zinacef and associated names (see Annex I) 500 mg powder and solvent for solution for injection Zinacef and associated names (see Annex I) 750 mg powder and solvent for solution for injection Zinacef and associated names (see Annex I) 1 g powder and solvent for solution for injection Zinacef and associated names (see Annex I) 750 mg powder for solution for infusion Zinacef and associated names (see Annex I) 1.5 g powder for solution for infusion Zinacef and associated names (see Annex I) 2 g powder for solution for infusion Zinacef and associated names (see Annex I) 250 mg powder for solution for injection or infusion Zinacef and associated names (see Annex I) 750 mg powder for solution for injection or infusion Zinacef and associated names (see Annex I) 1.5 g powder for solution for injection or infusion Zinacef and associated names (see Annex I) 750 mg powder for solution for infusion (Monovial presentation)
Slovenian: Zinacef in povezana imena (glejte Prilogo I) 750 mg prašek za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 1,5 g prašek za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 250 mg prašek in vehikel za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 500 mg prašek in vehikel za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 750 mg prašek in vehikel za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 1 g prašek in vehikel za raztopino za injiciranje Zinacef in povezana imena (glejte Prilogo I) 750 mg prašek za raztopino za infundiranje Zinacef in povezana imena (glejte Prilogo I) 1,5 g prašek za raztopino za infundiranje Zinacef in povezana imena (glejte Prilogo I) 2 g prašek za raztopino za infundiranje Zinacef in povezana imena (glejte Prilogo I) 250 mg prašek za raztopino za injiciranje ali infundiranje Zinacef in povezana imena (glejte Prilogo I) 750 mg prašek za raztopino za injiciranje ali infundiranje Zinacef in povezana imena (glejte Prilogo I) 1,5 g prašek za raztopino za injiciranje ali infundiranje Zinacef in povezana imena (glejte Prilogo I) 750 mg prašek za raztopino za infundiranje (monoviala) Zinacef in povezana imena (glejte Prilogo I) 1,5 g prašek za raztopino za infundiranje (monoviala)
English: 250 mg powder for solution for injection 250 mg intramuscular intravenous
Slovenian: 250 mg prašek za raztopino za injiciranje 250 mg intramuskularno intravensko
English: 500 mg powder for solution for injection Italy - Curoxim
Slovenian: 500 mg prašek za raztopino za injiciranje Italija - Curoxim
English: The stability of cefuroxime sodium in Sodium Chloride Injection BP 0.9% w/v and in 5% Dextrose Injection is not affected by the presence of hydrocortisone sodium phosphate.
Slovenian: Prisotnost hidrokortizon-natrijevega fosfata ne vpliva na stabilnost natrijevega cefuroksimata v 0,9 % m/V raztopini natrijevega klorida za injiciranje (BP) in 5 % raztopini glukoze za injiciranje.
English: Antibacterial agent-associated pseudomembranous colitis has been reported with use of cefuroxime and may range in severity from mild to life threatening.
Slovenian: Med uporabo cefuroksima je bil opisan psevdomembranozni kolitis, povezan s protibakterijskimi zdravili; po izrazitosti lahko sega od blagega do smrtno nevarnega.
English: 1.5 g cefuroxime sodium constituted with 15 mL Water for Injection may be added to metronidazole injection (500 mg/100 ml) and both retain their activity for up to 24 hours below 25 oC. 1.5 g cefuroxime sodium is compatible with azlocillin 1 g (in 15 ml) or 5 g (in 50 ml) for up to 24 h at 4oC or 6 h below 25oC.
Slovenian: 1,5 g natrijevega cefuroksimata je kompatibilno z 1 g azlocilina (v 15 ml) ali 5 g azlocilina (v 50 ml), in sicer: do 24 ur pri temperaturi 4°C ali 6 ur pri temperaturi do 25°C.
English: Concentrations of cefuroxime in excess of the minimum inhibitory levels for common pathogens can be achieved in the tonsilla, sinus tissues, bronchial mucosa, bone, pleural fluid, joint fluid, synovial fluid, interstitial fluid, bile, sputum and aqueous humour.
Slovenian: Povprečen volumen porazdelitve po intramuskularni ali intravenski uporabi odmerkov v razponu od 250 do 1000 mg sega od 9,3 do 15,8 l/1,73 m2. Koncentracije cefuroksima, ki presegajo minimalno inhibitorno koncentracijo za običajne patogene, je mogoče doseči v mandljih, sinusnih tkivih, bronhialni sluznici, kosteh, plevralni tekočini, sklepni tekočini, sinovijski tekočini, intersticijski tekočini, žolču, sputumu in očesni vodici.
English: 1 g powder for solution for injection or infusion Italy - Curoxim
Slovenian: 1 g prašek za raztopino za injiciranje ali infundiranje Italija - Curoxim
English: 2 g powder for solution for infusion Italy - Curoxim
Slovenian: 2 g prašek za raztopino za infundiranje Italija - Curoxim
English: Complicated urinary tract infections, including pyelonephritis Soft-tissue infections: cellulitis, erysipelas and wound infections
Slovenian: Odmerek pljučnica, dobljena v domačem okolju, in akutno poslabšanje kroničnega bronhitisa okužbe mehkih tkiv: celulitis, erizipel in okužbe ran intraabdominalne okužbe
English: Renal function should be monitored in the elderly and those with known pre-existing renal impairment (see section 4.2).
Slovenian: Pri starostnikih in bolnikih, ki že imajo okvaro ledvic, je potrebno spremljanje delovanja ledvic (glejte poglavje 4.2).
English: Streptococcus mitis (viridans group)
Slovenian: Streptococcus mitis (skupina viridans) Po Gramu negativni aerobi:
English: There was no evidence of accumulation of cefuroxime in the serum from normal volunteers following repeat intravenous administration of 1500 mg doses every 8 hours.
Slovenian: Po ponavljajoči se intravenski uporabi 1500-mg odmerkov na 8 ur v serumu zdravih prostovoljcev niso odkrili znakov kopičenja cefuroksima.
English: Cephalosporin antibiotics at high dosage should be given with caution to patients receiving concurrent treatment with potent diuretics such as furosemide or aminoglycosides.
Slovenian: Pri bolnikih, ki se zdravijo z močnimi diuretiki, npr. furosemidom ali aminoglikozidi, je potrebna previdnost pri dajanju visokih odmerkov cefalosporinskih antibiotikov, saj so pri tovrstnih kombinacijah poročali o okvarah ledvic.
English: 750 mg Monovial powder for solution for infusion Italy - Curoxim
Slovenian: 750 mg prašek za raztopino za infundiranje, monoviala Italija - Curoxim
English: Zinacef 250 mg , 750 mg and 1.5 g powder for solution for injection; Zinacef 250 mg, 750 mg and 1.5 g powder for solution for injection or infusion Intramuscular or intravenous use.
Slovenian: Zinacef 250 mg , 750 mg in 1,5 g prašek za raztopino za injiciranje; Zinacef 250 mg, 750 mg in 1,5 g prašek za raztopino za injiciranje ali infundiranje Intramuskularna ali intravenska uporaba.
English: Zinacef 250 mg , 750 mg and 1.5 g powder for solution for injection; Zinacef 250 mg, 750 mg and 1.5 g powder for solution for injection or infusion IM/IV.
Slovenian: Zinacef 250 mg , 750 mg in 1,5 g prašek za raztopino za injiciranje; Zinacef 250 mg, 750 mg in 1,5 g prašek za raztopino za injiciranje ali infundiranje i.m/i.v.
English: Tell your doctor before you are given Zinacef:
Slovenian: Preden prejmete zdravilo Zinacef, se morate z zdravnikom posvetovati:
English: PARTICULARS TO APPEAR ON IMMEDIATE PACKAGING VIAL LABEL
Slovenian: PODATKI NA STIČNI OVOJNINI NALEPKA NA VIALI
English: Zinacef 250 mg, 500 mg, 750 mg and 1 g powder and solvent for solution for injection Intramuscular or intravenous use.
Slovenian: Zinacef 250 mg, 500 mg, 750 mg in 1 g prašek in vehikel za raztopino za injiciranje Intramuskularna ali intravenska uporaba.
English: Following intravenous (IV) doses of 750 and 1500 mg, serum concentrations were approximately 50 and 100 µg/mL, respectively, at 15 minutes.
Slovenian: vnosu so bile pri 750 mg odmerku 50 µg/ml in pri 1500 mg približno 100 µg/ml.
English: mEqL) in 0.9% Sodium Chloride Injection.
Slovenian: 0,9 % m/V raztopini natrijevega klorida za injiciranje (BP);
English: INSTRUCTIONS ON USE [To be completed nationally]
Slovenian: POSEBNA NAVODILA ZA SHRANJEVANJE [izpolni država članica]
English: Vial size
Slovenian: Velikost viale
English: Zinacef 750 mg and 1.5 g powder for solution for infusion (Monovial presentation) Intravenous use.
Slovenian: Zinacef 750 mg in 1,5 g prašek za raztopino za infundiranje (monoviala) Intravenska uporaba.
English: Zinacef strength
Slovenian: Jakost zdravila Zinacef
English: 750 mg, 1.5 g powder for solution for infusion (Monovial presentation).
Slovenian: 750 mg, 1,5 mg prašek za raztopino za infundiranje (monoviala).
English: Zinacef 750 mg, 1.5 g and 2 g powder for solution for infusion IV
Slovenian: Zinacef 750 mg, 1,5 g in 2 g prašek za raztopino za infundiranje
English: 250 mg, 500 mg, 750 mg, 1 g powder and solvent for solution for injection Powder and solvent for solution for injection [To be completed nationally]
Slovenian: 250 mg, 500 mg, 750 mg, 1 g prašek in vehikel za raztopino za injiciranje Prašek in vehikel za raztopino za injiciranje [izpolni država članica]
English: Zinacef 250 mg, 500 mg, 750 mg and 1 g powder and solvent for solution for injection IM/IV
Slovenian: Zinacef 250 mg, 500 mg, 750 mg in 1 g prašek in vehikel za raztopino za injiciranje i.m/i.v.
English: 30 to 100 mg/kg/day (intravenously) given as 3 or 4 divided doses; a dose of 60 mg/kg/day is appropriate for most infections
Slovenian: pljučnica, dobljena v domačem okolju zapletene okužbe sečil, vključno s pielonefritisom okužbe mehkih tkiv: celulitis, erizipel in okužbe ran intraabdominalne okužbe od 30 do 100 mg/kg/dan (intravensko) v 3 ali 4 deljenih odmerkih; za večino okužb je primeren odmerek 60 mg/kg/dan od 30 do 100 mg/kg/dan (intravensko) v 2 ali 3 deljenih odmerkih (glejte poglavje 5.2)
English: 750 mg, 1.5 g, 2 g powder for solution for infusion Powder for solution for infusion [To be completed nationally]
Slovenian: 750 mg, 1,5 g, 2 g prašek za raztopino za infundiranje Prašek za raztopino za infundiranje [izpolni država članica]
English: 250 mg, 750 mg, 1.5 g powder for solution for injection or infusion Powder for solution for injection or infusion [To be completed nationally]
Slovenian: 250 mg, 750 mg, 1,5 g prašek za raztopino za injiciranje ali infundiranje Prašek za raztopino za injiciranje ali infundiranje [izpolni država članica]
English: Heparin (10 and 50 units/ml) in 0.9% Sodium Chloride Injection; Potassium Chloride (10 and 40
Slovenian: Če so natrijev cefuroksimat dodali intravenski infuziji s heparinom (10 in 50 enot/ml) v 0,9 % raztopini natrijevega klorida za injiciranje ali intravenski infuziji s kalijevim kloridom (10 in 40 mEql) v 0,9 % raztopini natrijevega klorida za injiciranje, je bila pri sobni temperaturi ugotovljena kompatibilnost v trajanju 24 ur.
English: 250 mg, 750 mg, 1.5 g powder for solution for injection Powder for solution for injection [To be completed nationally]
Slovenian: 250 mg, 750 mg, 1,5 g prašek za raztopino za injiciranje Prašek za raztopino za injiciranje [izpolni država članica]
English: Zinacef 750 mg, 1.5 g and 2 g powder for solution for infusion Intravenous use.
Slovenian: Zinacef 750 mg, 1,5 g in 2 g prašek za raztopino za infundiranje i.v.
English: Other Interactions
Slovenian: DRUGI PODATKI
English: Zinacef 750 mg and 1.5 g powder for solution for infusion (Monovial presentation)
Slovenian: Zinacef 750 mg in 1,5 g prašek za raztopino za infundiranje (monoviala)
English: Paediatrics
Slovenian: Pediatrična uporaba
English: Uncommon side effects
Slovenian: Pogosti neželeni učinki
English: • Community acquired pneumonia.
Slovenian: • pljučnica, dobljena v domačem okolju;
English: 750 mg once daily
Slovenian: 750 mg enkrat na dan bolniki na hemodializi
English: Caution should be used if cefuroxime is given to patients with a history of non-severe hypersensitivity to other beta-lactam agents.
Slovenian: Pri bolnikih z anamnezo preobčutljivosti na druga betalaktamska zdravila, ki ni bila huda, je v primeru uporabe cefuroksima potrebna previdnost.
English: 5% Dextrose and 0.45% Sodium Chloride Injection 5% Dextrose and 0.225% Sodium Chloride Injection 10% Dextrose Injection
Slovenian: 4 % raztopini glukoze v 0,18 % m/V raztopini natrijevega klorida za injiciranje (BP); - 5 % raztopini glukoze v 0,9 % raztopini natrijevega klorida za injiciranje; - 5 % raztopini glukoze v 0,45 % raztopini natrijevega klorida za injiciranje; - 5 % raztopini glukoze v 0,225 % raztopini natrijevega klorida za injiciranje; - 10 % raztopini glukoze za injiciranje; - 10 % raztopini invertnega sladkorja v vodi za injekcije; - Ringerjevi raztopini za injiciranje (USP); - raztopini Ringerjevega laktata za injiciranje (USP); - M/6 raztopini natrijevega laktata za injiciranje; - sestavljeni raztopini natrijevega laktata za injiciranje (Hartmannova raztopina) (BP).
English: However, this should not lead to false-positive results, as may be experienced with some other cephalosporins.
Slovenian: Pri uporabi bakrovih redukcijskih testov (Benedictov test, Fehlingov test, Clinitest) se rahel vpliv sicer lahko opazi, vendar pa zaradi tega ne bi smelo prihajati do lažno pozitivnih rezultatov, kakršni se lahko pričakujejo pri nekaterih drugih cefalosporinih.
English: Contact a doctor or nurse immediately if you get any of these symptoms.
Slovenian: Če se vam pojavi kateri od teh simptomov, se takoj obrnite na zdravnika ali medicinsko sestro.
English: stomach pain
Slovenian: • trebuha.
English: Zinacef 750 mg and 1.5 g powder for solution for infusion (Monovial presentation) IV
Slovenian: Zinacef 750 mg, in 1,5 g in prašek za raztopino za infundiranje (monoviala) i.v.
English: No data are available for women under 18 years.
Slovenian: Podatki za ženske, mlajše od 18 let, niso na voljo.
English: The dose of 200 mg should not be exceeded.
Slovenian: Odmerek 200 mg se ne sme preseči.
English: The Mifepristone Linepharma tablet should be swallowed with some water in the presence of a doctor or a member of his/her medical staff.
Slovenian: Tableto Mifepristone Linepharma je treba pogoltniti z nekaj vode ob prisotnosti zdravnika ali člana njegovega zdravstvenega osebja.
English: Note: These amendments to the summary of product characteristics and package leaflet are valid at the time of the Commission Decision.
Slovenian: Opomba: Te spremembe povzetka glavnih značilnosti zdravila in navodila za uporabo so veljavne ob izdaji odločbe Komisije.
English: Medical termination of developing intra-uterine pregnancy up to 63 days of amenorrhea.
Slovenian: Prekinitev znotrajmaternične nosečnosti z zdravili do 63 dni amenoreje.